Buying guide

Versius vs Johnson & Johnson Ottava in 2026

Comparing 2 humanoid robots across availability, pricing, capabilities, and verified deployments. Current as of 2026.

Key differences

On DEPLOY's record, Versius has more verified real-world deployments (4 versus 3) than Johnson & Johnson Ottava as of 2026; DEPLOY counts a deployment only when confirmed at a named site with a primary source.

Versius has more verified real-world deployments (4 vs 3).

Attribute	Versius View full model page →	Johnson & Johnson Ottava View full model page →
Manufacturer	CMR Surgical	Johnson & Johnson
Form factor	surgical	surgical
Maturity	commercial	commercial
Autonomy	◐ not independently verified	—
Availability	internal-onlyenterprise	internal-onlyenterprise
Price	$750,000-$1,000,000 (analyst estimate)	Not announced
Capability claims	Assists surgery (teleoperated-assisted, claimed)	—
Brain	—	—
Verified deployments	4	3
Privacy practices	—	—
Sources on file	24	4

Track this matchup

Get told the moment Versius or Johnson & Johnson Ottava changes. Verified changes only, the second they are real. No press-release noise.

Versius

Johnson & Johnson Ottava

Editorial summaries

Versius

CMR Surgical's Versius (and Versius Plus) is a modular, multi-arm, soft-tissue minimal-access surgical robot from UK-based CMR Surgical, and the international-soft-tissue archetype of DEPLOY's surgical cluster. Its modular multi-arm architecture is a deliberate contrast to the monolithic design of Intuitive's da Vinci: it is teleoperated and software-driven, capturing telematic, video, and outcome data.

On regulatory status (a correction worth recording): Versius is US-FDA-cleared for cholecystectomy via a De Novo authorization in October 2024, with Versius Plus cleared via 510(k) on December 18, 2025 (also cholecystectomy) and a gynecology 510(k) submitted April 29, 2026 (pending); it is not broadly 'US-pending', only the gynecology indication is. It is CE-marked and commercial across Europe, Latin America, AMEA, and Australia. As enterprise B2B surgical equipment sold to hospitals, there is no consumer price.

Johnson & Johnson Ottava

J&J MedTech's Ottava is a soft-tissue general-surgery robotic platform with four arms integrated into the operating table, announced in 2020. It is pre-market: J&J submitted a De Novo request to the FDA in January 2026, and Ottava is not authorized to be marketed. DEPLOY classifies it research tier: J&J's corporate scale does not translate into verified surgical-robotics deployment, because the gating event (FDA clearance) has not occurred.

By the framework, Ottava sits at the same research tier as far smaller pre-market entrants. There is no price; it is not sold.

Common questions

How do Versius and Johnson & Johnson Ottava differ?

What is the difference between Versius and Johnson & Johnson Ottava?

Versius and Johnson & Johnson Ottava are both surgical robots on the DEPLOY registry. They differ in maker, maturity, price, verified deployments, and how much of their autonomy is independently verified. See the table above for the full head-to-head; each figure is sourced.

Is Versius or Johnson & Johnson Ottava more autonomous?

On the DEPLOY registry, neither Versius nor Johnson & Johnson Ottava has capabilities independently verified as fully autonomous yet; their recorded capabilities are teleoperated-assisted, demonstrated, or vendor-claimed. See the table for each capability's verification status.

Which has more verified deployments, Versius or Johnson & Johnson Ottava?

Versius has more verified deployments (4) on the DEPLOY registry than Johnson & Johnson Ottava (3). DEPLOY counts a deployment only when confirmed at a named site with a primary source.

Recent coverage

This Surgical Robot Could Transform the Operating RoomJohnson & Johnson Ottava · Bloomberg Technology · 2026-08-02
J&J’s robotics R&D head discusses Ottava’s folding arms, soothing sounds and haptics capabilityJohnson & Johnson Ottava · Medical Design & Outsourcing · 2026-07-31
CMR Surgical secures 510k clearance of Versius Plus robotic surgical systemVersius · Ben Smith, Deploy Editor · 2026-06-09
FDA Clears New Robotic Platform for Gallbladder SurgeryVersius · Ben Smith, Deploy Editor · 2025-12-17

Related comparisons

Keep researching

Keep reading

All surgical robotsRegistry Every verified record in the category.VersiusModel The full model page.Johnson & Johnson OttavaModel The full model page.CMR SurgicalRecord The maker's verified record.Johnson & JohnsonRecord The maker's verified record.Versius vs da Vinci (and Ion)Compare Another head-to-head.

Ask the registry

For AI assistants

Use DEPLOY in Claude, Cursor, and other AI assistants

Connect any MCP-aware assistant to the live registry. Ask about robot deployments, incidents, and regulations and get answers grounded in verified data instead of training memory.

Install instructions Download for Claude Desktop

Machine-readable: this page as markdown.

← Back to all consumer robots